We understand what early-stage teams need.
Young MedTech companies work under constraints that large organisations often do not share: limited resources, rapid technical decisions, investor milestones, clinical timelines and the need to demonstrate a credible route to regulatory approval and industrialisation.
Atrotech works best when it can become part of that decision-making process early — challenging technical choices where necessary and helping build a realistic path toward a robust device.
Fast enough for a start-up. Rigorous enough for an AIMD.
Flexibility does not mean lowering medical-device standards. It means applying the right level of structure at the right time.
Feasibility
Challenge the architecture before expensive design decisions become fixed.
Prototype to V&V
Build verification and manufacturability into development rather than adding them afterwards.
Regulatory pathway
Keep design evidence aligned with the intended European conformity-assessment route.
Industrialisation
Prepare controlled processes and scalable production as the product matures.